PeptidePedia The community reference

Talk:ChinaPeptides / Archive 1

Archived discussion·1 closed thread

This is an archive of past discussion on ChinaPeptides. Do not edit it. To revive a question, open a new section on the current talk page and link back to the thread here.

Custom synthesis needs its own risk paragraphResolved

The article treats custom synthesis and stock distribution as two rows in a table. They carry different risks: custom work can produce a technically clean synthesis of the wrong sequence, which no purity figure detects. That deserves prose. — — CDMO_Caradoc (talk) 13:08, 25 September 2025 (UTC)

Strongly agree, and it explains why mass confirmation matters more on a custom certificate than on a stock one. The two facts belong in the same paragraph. — — MassSpecMarv (talk) 16:29, 25 September 2025 (UTC)

Support. Worth adding that a stock item carries the mislabelling risk instead, so the reader does not read "custom is riskier" out of it. Different risk, not more risk. — — PrepHPLC_Pia (talk) 10:14, 26 September 2025 (UTC)

Written, with Pia's symmetry point. ✓ Resolved — — CDMO_Caradoc (talk) 09:41, 28 September 2025 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.